JP2001509168A5 - - Google Patents

Download PDF

Info

Publication number
JP2001509168A5
JP2001509168A5 JP1998532249A JP53224998A JP2001509168A5 JP 2001509168 A5 JP2001509168 A5 JP 2001509168A5 JP 1998532249 A JP1998532249 A JP 1998532249A JP 53224998 A JP53224998 A JP 53224998A JP 2001509168 A5 JP2001509168 A5 JP 2001509168A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998532249A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001509168A (ja
Filing date
Publication date
Priority claimed from US08/801,352 external-priority patent/US5846225A/en
Application filed filed Critical
Priority claimed from PCT/US1998/001638 external-priority patent/WO1998032859A1/en
Publication of JP2001509168A publication Critical patent/JP2001509168A/ja
Publication of JP2001509168A5 publication Critical patent/JP2001509168A5/ja
Ceased legal-status Critical Current

Links

JP53224998A 1997-01-29 1998-01-29 血管新生を誘導するためのアデノウイルスベクターの多部位送達 Ceased JP2001509168A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US3660197P 1997-01-29 1997-01-29
US60/036,601 1997-01-29
US08/801,352 US5846225A (en) 1997-02-19 1997-02-19 Gene transfer therapy delivery device and method
US7115698P 1998-01-13 1998-01-13
US08/801,352 1998-01-13
US60/071,156 1998-01-13
PCT/US1998/001638 WO1998032859A1 (en) 1997-01-29 1998-01-29 Multiple site delivery of adenoviral vector for the induction of angiogenesis

Publications (2)

Publication Number Publication Date
JP2001509168A JP2001509168A (ja) 2001-07-10
JP2001509168A5 true JP2001509168A5 (enExample) 2005-09-08

Family

ID=27365066

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53224998A Ceased JP2001509168A (ja) 1997-01-29 1998-01-29 血管新生を誘導するためのアデノウイルスベクターの多部位送達

Country Status (16)

Country Link
US (2) US6518255B2 (enExample)
EP (1) EP1012291B1 (enExample)
JP (1) JP2001509168A (enExample)
KR (1) KR20000070572A (enExample)
AT (1) ATE279518T1 (enExample)
AU (1) AU745409B2 (enExample)
BR (1) BR9806819A (enExample)
CA (1) CA2278621A1 (enExample)
DE (1) DE69827021T2 (enExample)
HU (1) HUP0001964A3 (enExample)
IL (1) IL131021A0 (enExample)
MX (1) MXPA99006993A (enExample)
NO (1) NO993669L (enExample)
NZ (1) NZ336838A (enExample)
PL (1) PL334902A1 (enExample)
WO (1) WO1998032859A1 (enExample)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7238673B2 (en) 1989-03-31 2007-07-03 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
ATE279518T1 (de) * 1997-01-29 2004-10-15 Cornell Res Foundation Inc An verschiedenen orten verabreichung von adenoviren-vektor zur induzierung von angiogenese
US6775574B1 (en) * 1997-11-07 2004-08-10 Medtronic, Inc. Method and system for myocardial infarction repair
US6251079B1 (en) 1998-09-30 2001-06-26 C. R. Bard, Inc. Transthoracic drug delivery device
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
ES2316194T3 (es) 1998-10-28 2009-04-01 Cornell Research Foundation, Inc. Metodos para la regulacion de la angiogenesis y la integridad vascular utilizando los ligandos bdnf, nt-3 y nt-4.
AU5646300A (en) * 1999-02-10 2000-08-29 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods of stimulating angiogenesis
US6986784B1 (en) 1999-05-14 2006-01-17 C. R. Bard, Inc. Implant anchor systems
US6440945B1 (en) * 1999-05-27 2002-08-27 Instituto Dermopatico Dell'immacolata Method of inducing angiogenesis in nonis chemic skeletal muscle
WO2000078358A2 (en) * 1999-06-18 2000-12-28 The Collaborative Group, Ltd. Hyaluronic acid microspheres for sustained gene transfer
EP1067190A1 (en) * 1999-07-09 2001-01-10 Introgene B.V. Gene therapy for enhancing and/or inducing angiogenesis
US6855160B1 (en) 1999-08-04 2005-02-15 C. R. Bard, Inc. Implant and agent delivery device
EP1199992A1 (en) 1999-08-05 2002-05-02 Cornell Research Foundation, Inc. Gene therapy platformed needle and method of administering a therapeutic solution to a heart
FR2799465B1 (fr) * 1999-10-12 2004-02-13 Centre Nat Rech Scient Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
CN1433325A (zh) * 1999-11-05 2003-07-30 加利福尼亚大学董事会 通过体内基因递送治疗心血管疾病的技术和组合物
US6329348B1 (en) * 1999-11-08 2001-12-11 Cornell Research Foundation, Inc. Method of inducing angiogenesis
US7232421B1 (en) 2000-05-12 2007-06-19 C. R. Bard, Inc. Agent delivery systems
US6508802B1 (en) 2000-05-23 2003-01-21 Cornell Research Foundation, Inc. Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart
US7204847B1 (en) 2000-07-28 2007-04-17 C. R. Bard, Inc. Implant anchor systems
US6939540B1 (en) 2000-07-31 2005-09-06 Cornell Research Foundation, Inc. Method of enhancing bone density
MXPA02003434A (es) * 2000-08-04 2002-09-02 Human Genome Sciences Inc Factor de crecimiento endotelial vascular 2.
US20040009940A1 (en) * 2000-10-20 2004-01-15 Coleman Michael E. Gene delivery formulations and methods for treatment of ischemic conditions
EP1330252A4 (en) * 2000-11-01 2007-12-26 Ludwig Inst Cancer Res IN VIVO STIMULATION OF ANGIOGENIC ACTIVITY
EP1361896A2 (en) * 2001-01-23 2003-11-19 Boston Scientific Corporation Localized myocardial injection method for treating ischemic myocardium
AR027161A1 (es) 2001-05-15 2003-03-19 Bio Sidus S A Metodo para inducir la proliferacion neovascular y regeneracion tisular
CA2406687A1 (en) * 2001-11-09 2003-05-09 Transgene S.A. Chimeric promoters for controlling expression in muscle cells
CA2501232A1 (en) * 2002-11-15 2004-06-03 Genvec, Inc. Coronary artery disease treatment
DK1732588T3 (da) 2004-04-05 2009-10-12 Univ California Modulation af NKG2D
WO2006072625A2 (en) 2005-01-06 2006-07-13 Novo Nordisk A/S Anti-kir combination treatments and methods
RU2321631C2 (ru) * 2005-06-24 2008-04-10 Государственное учреждение Российский научный центр хирургии РАМН Неинфекционный для человека аденовирус как вектор для заместительной генной терапии нарушений ангиогенеза, обеспечивающий эффективный синтез ангиогенина человека в трансфецированных клетках млекопитающих, способ индукции ангиогенеза, способ лечения ишемической болезни, композиция для индукции ангиогенеза и лечения ишемической болезни
US7751883B2 (en) 2006-04-25 2010-07-06 Eugenio Picano System and method for promoting coronary angiogenesis
US9598673B2 (en) * 2006-05-19 2017-03-21 Creative Medical Health Treatment of disc degenerative disease
US8983570B2 (en) * 2007-03-27 2015-03-17 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treatment of the spine
US11224635B2 (en) 2007-03-27 2022-01-18 Venturis Thereuptics, Inc. Therapeutic angiogenesis for treatment of the spine and other tissues
EP2612867A1 (en) 2007-11-01 2013-07-10 Perseid Therapeutics LLC Immunosuppressive polypeptides and nucleic acids
US8409147B2 (en) * 2009-08-22 2013-04-02 Joseph Wayne Kraft Rapid local anesthesia linear injection device
US8088108B2 (en) * 2009-08-22 2012-01-03 Joseph Wayne Kraft Rapid local anesthesia injection cone
WO2011026041A2 (en) 2009-08-28 2011-03-03 The Cleveland Clinic Foundation Sdf-1 delivery for treating ischemic tissue
WO2014036222A1 (en) * 2012-08-30 2014-03-06 Emory University Systems, methods and computer readable storage media storing instructions for integrating fluoroscopy venogram and myocardial images
HUE068364T2 (hu) * 2013-01-17 2024-12-28 Medizinische Hochschule Hannover Faktor 1 fehérje betegségek kézélésében vagy megelõzésében váló alkalmazásra
US11421229B2 (en) 2015-02-20 2022-08-23 Baylor College Of Medicine p63 inactivation for the treatment of heart failure
EP3329930A1 (en) 2016-12-05 2018-06-06 Nuritas Limited Pharmaceuctical compositions
JP2020504714A (ja) 2016-12-05 2020-02-13 ニューリタス リミテッド ペプチドｗｋｄｅａｇｋｐｌｖｋを含む組成物
WO2021072272A1 (en) * 2019-10-09 2021-04-15 Xylocor Therapeutics, Inc. Epicardial delivery of gene therapy
WO2024233783A1 (en) 2023-05-09 2024-11-14 Cornell University Expression cassette coding for vascular endothelial growth factor

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US510413A (en) 1893-12-12 Drainage-tube
US2551902A (en) 1948-09-10 1951-05-08 Arthur Schaffer Dehorning fluid ejector
US2670673A (en) 1950-07-17 1954-03-02 Joyce A Gordon Fluid injecting device
US3467096A (en) 1966-04-12 1969-09-16 Ferrell S Horn Multiple hypodermic syringe arrangement
FR1584474A (enExample) 1968-02-20 1969-12-26
US3572336A (en) 1968-04-30 1971-03-23 Daniel R Hershberg Syringe
US4150669A (en) 1977-03-16 1979-04-24 Alvaro Latorre Apparatus for effecting and enhancing an erection
US4167179A (en) 1977-10-17 1979-09-11 Mark Kirsch Planar radioactive seed implanter
US5335670A (en) 1986-04-18 1994-08-09 Henry Fishman Allergy testing method and apparatus
JPS6438100A (en) 1987-07-31 1989-02-08 Toray Industries Vascular endothelial cell growth factor
JPH02117698A (ja) 1988-10-27 1990-05-02 Toray Ind Inc 血管内皮細胞成長因子
US5240848A (en) 1988-11-21 1993-08-31 Monsanto Company Dna sequences encoding human vascular permeability factor having 189 amino acids
JPH02279698A (ja) 1989-04-20 1990-11-15 M K Medical:Kk 血管内皮細胞成長因子及びその製造方法
US5332671A (en) 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
CA2017379C (en) 1989-05-24 2002-06-25 Kenneth A. Thomas, Jr. Purification and characterization of a glioma-derived growth factor
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
JPH03178996A (ja) 1989-12-06 1991-08-02 Makoto Goto 成長因子
US6228844B1 (en) * 1991-11-12 2001-05-08 Vical Incorporated Stimulating vascular growth by administration of DNA sequences encoding VEGF
DE69132040T2 (de) 1990-09-21 2000-11-02 Merck & Co., Inc. Wachstumsfaktor II für vaskuläre Endothelzellen
EP0506477B1 (en) 1991-03-28 1999-06-23 Merck & Co. Inc. Vascular endothelial cell growth factor C subunit
US5244460A (en) 1991-11-27 1993-09-14 The United States Of America As Represented By The Department Of Health And Human Services Method to foster myocardial blood vessel growth and improve blood flow to the heart
EP0550296A3 (en) 1991-11-28 1993-12-29 Terumo Corp Vascular endothelial cells growth factor
US5290258A (en) 1992-07-27 1994-03-01 Genesis Industries, Inc. Syringe for administering sequentially multiple doses of a medicament
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US6177401B1 (en) * 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
DK0751992T3 (da) 1994-03-08 2006-03-06 Human Genome Sciences Inc Karendotelvækstfaktor 2
US5851806A (en) * 1994-06-10 1998-12-22 Genvec, Inc. Complementary adenoviral systems and cell lines
US5417683A (en) 1994-07-13 1995-05-23 Shiao; I-Shen Mini-graft hair implanting device for implanting multiple clumps of hair follicles at one time
JPH10507758A (ja) * 1994-10-19 1998-07-28 ジェネティック セラピー，インコーポレイテッド アデノウイルスおよび免疫抑制剤同時反復投与を伴う遺伝子治療
US5792453A (en) * 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
JP3178996B2 (ja) 1995-08-24 2001-06-25 沖電気工業株式会社 カード処理装置及びカード送り速度の制御方法
US6121246A (en) 1995-10-20 2000-09-19 St. Elizabeth's Medical Center Of Boston, Inc. Method for treating ischemic tissue
ATE279518T1 (de) * 1997-01-29 2004-10-15 Cornell Res Foundation Inc An verschiedenen orten verabreichung von adenoviren-vektor zur induzierung von angiogenese
US5846225A (en) 1997-02-19 1998-12-08 Cornell Research Foundation, Inc. Gene transfer therapy delivery device and method
JP3371331B2 (ja) * 1998-12-14 2003-01-27 セイコーエプソン株式会社 インクジェット式記録ヘッドおよびその製造方法

Similar Documents

Publication Publication Date Title
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000509912A5 (enExample)
JP2000509635A5 (enExample)
JP2000509637A5 (enExample)
JP2000509587A5 (enExample)
JP2002507354A5 (enExample)
JP2001507937A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2001509168A5 (enExample)
JP2000508841A5 (enExample)
JP2002511864A5 (enExample)
JP2001514767A5 (enExample)
JP2001524054A5 (enExample)
JP2001508116A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510247A5 (enExample)
JP2000510969A5 (enExample)
JP2000508836A5 (enExample)
JP2000509520A5 (enExample)
JP2000509818A5 (enExample)
JP2002510417A5 (enExample)